论文部分内容阅读
马拉维开展了一项全国性调查以评价治疗 5 个月或更长时间后痰涂片仍然为阳性新发涂阳肺结核病人的管理情况。2000 年到 2001 年,共有此类病人 250 例,其中161 例(64%)在治疗 5 个月后查痰阳性,另 89 例在治疗7 个月后查痰阳性。该研究发现了治疗管理上数个需要改进的不一致和不充分之处,包括 7%的评价病人只有一份痰涂片,而不是两份,17%的病人根据一份阳性结果作出结论;47%的5 个月阳性病人和 52%的7 个月阳性病人存在痰涂片检查过早或过晚的现象;14%的 5 个月阳性病人在继续治疗,但其中超过 60%者却记录为“治愈”。
Malawi conducted a national survey to assess the management of new smear-positive pulmonary tuberculosis patients who were still positive for sputum smear after 5 months of treatment or longer. Between 2000 and 2001, there were 250 such patients, of which 161 (64%) were sputum positive after 5 months of treatment and the other 89 were sputum positive after 7 months of treatment. The study identified several areas of inconsistency and inadequacies in treatment management that needed improvement, including 7% of patients evaluated with only one sputum smear instead of two and 17% of patients concluding on the basis of a positive result; 47 Fifty percent of positive patients in 5 months and 52% of positive patients in 7 months had early or late sputum smear tests; 14% of 5-month positive patients continued treatment, but more than 60% of them were recorded as “cure”.